Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual Property
- DOI
- 10.1021/acsabm.6c00351
- Published
- 2026-04-27
- Container
- ACS Applied Bio Materials
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acsabm.6c00351,
title = {Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual Property},
author = {Aayushi Pandey and Rohit Bhawale and Ravindra Vasave and Omar Khan and Sri Pada Datta Chigurupati and Nalla Usha Kumari and Kshitiz Luthra and Neelesh Kumar Mehra},
year = {2026},
journal = {ACS Applied Bio Materials},
doi = {10.1021/acsabm.6c00351},
url = {https://doi.org/10.1021/acsabm.6c00351}
}RIS
TY - JOUR TI - Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual Property AU - Aayushi Pandey AU - Rohit Bhawale AU - Ravindra Vasave AU - Omar Khan AU - Sri Pada Datta Chigurupati AU - Nalla Usha Kumari AU - Kshitiz Luthra AU - Neelesh Kumar Mehra PY - 2026 JO - ACS Applied Bio Materials DO - 10.1021/acsabm.6c00351 UR - https://doi.org/10.1021/acsabm.6c00351 ER -
APA
Pandey, A., Bhawale, R., Vasave, R., Khan, O., Chigurupati, S. P. D., Kumari, N. U., Luthra, K., & Mehra, N. K. (2026). Uveitis Management at the Crossroads of Pharmacotherapy, Nanotechnology, and Intellectual Property. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00351
Source records
- crossref · retrieved 2026-09-25T13:45:41.405Z